Common Stock
- Symbol
- PMI
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Picard Medical, Inc.
PMINYSE_AMERICANEQUITYCurrent
Other Events
Item 8.01 Other Events. As previously disclosed in Picard Medical, Inc.'s (the "Company") Current Report on Form 8-K filed on July 2, 2026, the Company published a pre-recorded presentation (the “Presentation”) providing stockholders with an overview of the Company's recent business performance, product development progress, manufacturing initiatives, and the proposals to be considered at the Comp…
Company context
Picard Medical, Inc. is the parent company of SynCardia Systems, LLC (“SynCardia”), the Tucson, Arizona - based leader with the only commercially available total artificial heart technology for patients with end-stage heart failure. SynCardia develops, manufactures, and commercializes the SynCardia Total Artificial Heart (“STAH”), an implantable system that assumes the full functions of a failing or failed human heart. It is the first artificial heart approved by both the FDA and Health Canada, and it remains the only commercially available artificial heart in the United States and Canada. With more than 2,100 implants performed at hospitals across 27 countries, the STAH is the most widely used and extensively studied artificial heart in the world. For additional information about Picard Medical, please visit www.picardmedical.com or review the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”) at www.sec.gov.
Current securities
Recent company filings
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesOct 23, 2026
- S-3 filingOct 22, 2026
- Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearOct 13, 2026
- Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity SecuritiesOct 6, 2026
- Regulation FD DisclosureAug 20, 2026
Registered securities in this filing
Picard Medical, Inc. · 8-K · Filed 2026-07-02
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
As previously disclosed in Picard Medical, Inc.'s (the "Company") Current Report on Form 8-K filed on July 2, 2026, the Company published a pre-recorded presentation (the “Presentation”) providing stockholders with an overview of the Company's recent business performance, product development progress, manufacturing initiatives, and the proposals to be considered at the Company's 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. The Presentation is incorporated herein by reference. A copy of the transcript for the Presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are being filed herewith:
Exhibit No. Description
────────────────────────────────────────────────────────────────────────────────────────────────
99.1 Presentation transcript (July 2, 2026)
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)